J.P. Morgan Reaffirms Their Hold Rating on Becton Dickinson (BDX)
J.P. Morgan analyst maintained a Hold rating on Becton Dickinson yesterday and set a price target of $175.00.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to J.P. Morgan, Becton Dickinson also received a Hold from TD Cowen’s Josh Jennings in a report issued yesterday. However, on the same day, Barclays initiated coverage with a Buy rating on Becton Dickinson (NYSE: BDX).
Based on Becton Dickinson’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $5.25 billion and a net profit of $382 million. In comparison, last year the company earned a revenue of $5.17 billion and had a net profit of $303 million
Based on the recent corporate insider activity of 67 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BDX in relation to earlier this year. Last month, Michael David Garrison, the EVP & Pres Med.Essntl&BioPharm of BDX sold 1,610.00 shares for a total of $334,005.39.
Read More on BDX:
Disclaimer & DisclosureReport an Issue
- Becton Dickinson Launches $1.6 Billion Debt Tender Offers
- Under Armour cut to Sell, Snap upgraded: Wall Street’s top analyst calls
- Becton Dickinson price target lowered to $172 from $210 at RBC Capital
- Two new option listings and one option delisting on February 10th
- Waters resumed with an In Line at Evercore ISI
